2023年4月4日 · Erlotinib (Tarceva) is a type of targeted therapy used to treat pancreatic cancer and non-small cell lung cancer. It is a tyrosine kinase inhibitor that works by blocking the kinase activity of a protein called epidermal growth factor receptor (EGFR).

Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. [4] Specifically it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR) — either an exon 19 deletion (del19) or exon 21 (L858R) substitution mutation — which has ...

2020年3月18日 · Erlotinib is a tyrosine kinase receptor inhibitor approved by the US Food and Drug Administration (FDA) for the treatment of non-small cell lung cancer and advanced pancreatic cancer. This drug inhibits the epidermal growth factor receptor (EGFR), affecting both wild-type and mutated EGFRs, which are crucial in cellular differentiation ...

2025年3月1日 · Erlotinib is used for the treatment of metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) gene mutations.

适应症: 厄洛替尼/Erlotinib（商品名：特罗凯/Tarceva）于2004年11月18日获FDA批准上市，适用于肿瘤表皮生长因子受体（EGFR）19号外显子缺失或者21号外显子（L858R）突变的转移性非小细胞肺癌（NSCLC），也可联合吉西他滨（gemcitabine）作为一线治疗局部晚期、不可切除 ...

2024年10月12日 · 厄洛替尼（英语： erlotinib ）以Tarceva（中文译名"得舒缓"或"特罗凯"）等品牌于市面销售，是一种用于治疗 非小细胞肺癌 （ 英语 ： non-small-cell lung cancer ） （NSCLC）和胰脏癌的药物。

Erlotinib is used to treat lung and pancreatic cancer. It works by slowing or stopping the growth of cancer cells. Take this medication by mouth on an empty stomach (at least 1 hour...

2021年3月17日 · ERLOTINIB tablets, for oral use ... 1.1 Non-Small Cell Lung Cancer (NSCLC) Erlotinib tablets are indicated for: The treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth ...

2023年1月24日 · Erlotinib, a kinase inhibitor, is a quinazolinamine with the chemical name N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine. Erlotinib tablets contains erlotinib as the hydrochloride salt that has the following structural formula: Erlotinib hydrochloride has the molecular formula C 22 H 23 N 3 O 4 ∙HCl

Erlotinib is used to treat certain types of non-small cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been treated with at least one other chemotherapy medication and have not gotten better.